| 000 | 01728 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514230838.0 | ||
| 264 | 0 | _c20050728 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-04-3096 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJaggi, Jaspreet Singh | |
| 245 | 0 | 0 |
_aEfforts to control the errant products of a targeted in vivo generator. _h[electronic resource] |
| 260 |
_bCancer research _cJun 2005 |
||
| 300 |
_a4888-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aActinium _xadministration & dosage |
| 650 | 0 | 4 | _aAlpha Particles |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aBismuth _xchemistry |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrancium _xchemistry |
| 650 | 0 | 4 |
_aImmunotoxins _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLymphoma _xmetabolism |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aRadioimmunotherapy _xmethods |
| 650 | 0 | 4 |
_aSuccimer _xpharmacology |
| 650 | 0 | 4 |
_aUnithiol _xpharmacology |
| 700 | 1 | _aKappel, Barry J | |
| 700 | 1 | _aMcDevitt, Michael R | |
| 700 | 1 | _aSgouros, George | |
| 700 | 1 | _aFlombaum, Carlos D | |
| 700 | 1 | _aCabassa, Catalina | |
| 700 | 1 | _aScheinberg, David A | |
| 773 | 0 |
_tCancer research _gvol. 65 _gno. 11 _gp. 4888-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-04-3096 _zAvailable from publisher's website |
| 999 |
_c15591057 _d15591057 |
||